New Hopes For Stroke Patients
NeuroAidTM was historically developed in China as a traditional chinese medicine to help stroke patients achieve better rehabilitation. After 5 years, it is now reaching about 200,000 patients every year there.
Moleac, a biopharma company, is bringing NeuroAidTM to western medicine internationally and ensures it meets western medicine standards to attend to the needs of stroke sufferers : NeuroAidTM supports them to achieve better neurological and functional recovery.
Since 2006, patients in more that 15 countries have used Neuroaid™.
NeuroAidTM is to be taken by stroke patients after the stroke for better recovery of motor and cognitive functions.
Strong Efficacy and Safety data
NeuroaidTM clinical impact on neurological functions has been documented and published.
Several studies have been conducted on the efficacy for patients several months after their stroke. The Chimes trial is not evaluating the benefits of Neuroaid when given as soon as 48 hours after the stroke onset. It is currently recruiting 1100 patients in Asia.
NeuroAidTM safety profile has been validated by several trials which have shown it does not significantly affect hematological, hemostatis, and biochemical parameters nor interact with aspirin when started and maintained at the early stage of acute stroke. Neuroaid has been available in China for nearly 5 years and no severe adverse reactions were reported.

The Only Treatment Available
Rehabilitation and family care are the most important factors which promote recovery at late stage.
Many medicines prevent recurrence of stroke, but except aspirin in 1% of the cases, no medicine has been proven to enhance rehabilitation.
NeuroAidTM
is the only supplement available that enhances rehabilitation process, leading to better and faster recovery.
NeuroaidTM has been welcomed by the media and by clinicians worldwide. Our next international trial on 1,100 patients, conducted through the CHIMES society, has recently been awarded the biggest grant ever awarded in Singapore for a single clinical trial.
If you want to discuss Neuroaid with your doctors, you can download our discussion guide.